The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis

The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis

ABSTRACTAcute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now be...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Julia Stowe, Jamie Lopez-Bernal, Nick Andrews
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Taylor & Francis Group 2024-12-01
Sarja:Human Vaccines & Immunotherapeutics
Aiheet:
Acute disseminated encephalomyelitis (ADEM)
self-controlled case-series
COVID-19 vaccine safety
Linkit:https://www.tandfonline.com/doi/10.1080/21645515.2024.2311969

Samankaltaisia teoksia

Samankaltaisia teoksia